News

Although only 5% of active physicians are African American and 5.8% are Latino (2019 AAMC Diversity in Medicine report), Weill Cornell Medicine is dedicating time, energy and empathy to build inclusive environments. In recognition of Weill Cornell Medicine’s recent Diversity Week, the Weill Department of Medicine’s Grand Rounds on April 9, 2025 focused on the extraordinary work of the Cornell Center for Health Equity (CCHEq) and the Diversity Center of Excellence (DCOE), both...

The Women in Global Health Research’s upcoming intensive course on Global Infectious Diseases Across a Woman’s Lifespan, capped off by their 10th annual Scientific Symposium, takes place May 19-22, with the final day—May 22—open to the Weill Cornell Medicine community, including students and trainees. All are welcome to register.

The selective four-day intensive course will include topics such as sex differences in global infectious diseases; host immunology across the woman's lifespan...

A new preclinical study published Jan. 2 in Nature Immunology may lead to therapies that target the earliest stages of cancer, bolstering the idea the inflammasome has a dual role—that while promotes inflammation associated with poor outcomes in late cancer stages, early on it can help prevent cells from becoming cancerous in the first place.

“What was striking was that the innate immune system, which includes the inflammasome, has a role beyond infection,” said lead author Dr. Julie...

Findings published Jan. 29 in Science Advances from a team lead by senior author Dr. Shahin Rafii, chief of the division of Regenerative Medicine, found that adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study. The new approach, which requires further development and testing, could someday enable the much wider use of islet transplants to cure diabetes.

Islets, found in...